399 filings
Page 5 of 20
8-K
r7z00b8qv9a2kp3056s
31 May 19
Istaroxime Phase 2b Study Results Presented in Late Breaker Clinical Trial Session at the ESC Heart Failure Congress
4:17pm
8-K
7q4e77w8itucc
30 Apr 19
Windtree Therapeutics Appoints Daniel Geffken to Board of Directors
4:26pm
8-K
yldj8hz3zcteamlaph1p
22 Mar 19
Departure of Directors or Certain Officers
4:22pm
8-K/A
1tp6haytk2qz3p
8 Mar 19
Completion of Acquisition or Disposition of Assets
4:24pm
8-K
nw9 thvny9xkgs6c
31 Jan 19
Departure of Directors or Certain Officers
5:28pm
8-K
asysnvt87q0dxqu
3 Jan 19
Regulation FD Disclosure
7:03am
8-K
mp884gcs6n4v
31 Dec 18
Departure of Directors or Certain Officers
4:55pm
8-K
2fz278v
21 Dec 18
Windtree Therapeutics and CVie Therapeutics Announce Merger to Create a Global Acute Care Company Targeting Cardiovascular and Respiratory Diseases
5:28pm
8-K
zo4si054 6q6qr
14 Dec 18
Departure of Directors or Certain Officers
4:25pm
8-K
9c6t d7an9uc
7 Dec 18
Entry into a Material Definitive Agreement
5:02pm
8-K
1s90jv lbdc
7 Dec 18
Entry into a Material Definitive Agreement
12:00am
8-K
72pfg46
23 Nov 18
Entry into a Material Definitive Agreement
4:03pm
8-K
5jr50oe1zwkujuyu
8 Nov 18
Entry into a Material Definitive Agreement
4:20pm
8-K
putt kvdo
25 Oct 18
Entry into a Material Definitive Agreement
4:27pm
8-K
8a61e08 kbemqo
16 Oct 18
Entry into a Material Definitive Agreement
4:40pm
8-K
iq65s2ka0nzp8opy
3 Oct 18
Entry into a Material Definitive Agreement
4:41pm
8-K
7xcxj
14 Sep 18
Entry into a Material Definitive Agreement
12:00am
8-K
jbjsarv
29 Aug 18
Entry into a Material Definitive Agreement
12:00am
8-K
52b8 wvf0weqth3
27 Aug 18
Other Events
12:00am
8-K
bn02n
20 Aug 18
Entry into a Material Definitive Agreement
12:00am